Lab Volume Index
XIFIN analyzes its diagnostic billing data to measure laboratory testing volumes as compared to a baseline pre-Coronavirus testing average. Currently, XIFIN sees 15 - 20% of all COVID-19 and antibody testing claims nationwide, and analysis includes data representative of four out of five top integrated delivery networks (IDNs) and 10 of the top 12 public laboratories nationwide.
About the Laboratory Volume Index
The Lab Volume Index is a measurement of laboratory testing volumes as compared to a pre-COVID-19 testing average (“baseline”). Its synthesis of lab billing data into a measurement of testing volumes enables comparisons of routine laboratory testing, COVID-19 testing, and antibody testing both over time and across key laboratory segments: clinical, hospital, molecular, anatomic pathology, and pain/tox. Baseline volume is an average of weekly volumes generated late January through February 2020.
Weekly Analysis – March 14, 2021
XIFIN’s leadership team regularly offers a behind-the-scenes look at diagnostic laboratory through participation in industry discussions. Discussions include state of diagnostics industry, testing volumes and trends, the expected impact of the introduction of vaccines, advent of at-home testing, and more. Click to access the latest briefing.